Literature DB >> 10796767

Antibiotics for treating leptospirosis.

F Guidugli1, A A Castro, A N Atallah.   

Abstract

BACKGROUND: Leptospirosis is a parasitic disease transmitted by animals. Severe leptospirosis may result in hospitalisation and about five per cent of the patients die. In clinical practice, penicillin is widely used for treating leptospirosis.
OBJECTIVES: To evaluate the effectiveness and safety of antibiotics versus placebo or other antibiotic regimens in treating leptospirosis. We addressed the following clinical questions: a) Are treatment regimens with antibiotics more efficient than placebo for leptospirosis? b) Are treatment regimens with antibiotics safe when compared to placebo for leptospirosis? c) Which antibiotic regimen is the most efficient and safest in treating leptospirosis? SEARCH STRATEGY: Electronic searches and searches of the identified articles were combined. STUDIES: Randomised clinical trials in which antibiotics were used as treatment for leptospirosis. Language, date, or other restrictions were not applied. PARTICIPANTS: Patients with clinical manifestations of leptospirosis.
INTERVENTIONS: Any antibiotic regimen compared with a control group (placebo or another antibiotic regimen). DATA COLLECTION AND ANALYSIS: Data and methodological quality of each trial were independently extracted and assessed by two reviewers. The random effects model was used irrespective of significant statistical heterogeneity. MAIN
RESULTS: Three trials met inclusion criteria. Allocation concealment and double blind methods were not clearly described in two. Of the patients enrolled, 75 were treated with placebo and 75 with antibiotics: 61 (81.3%) penicillin and 14 (18.6%) doxycycline. The patients assigned to antibiotics compared to placebo showed: a) Mortality: 1% (1/75) versus 4% (3/75); risk difference -2%, 95% confidence interval -8% to 4%. b) Duration of hospital stay (days): weighted mean difference 0.30, 95% confidence interval -1.26 to 1.86. c) Prolonged hospital stay (> seven days): 30% (7/23) versus 74% (14/19); risk difference -43%, 95% confidence interval -70% to -16%. Number needed-to-treat 3, 95% confidence interval 2 to 7. d) Period of disappearance of fever (days): weighted mean difference -4.04, 95% confidence interval -8.65 to 0.58. e) Leptospiruria: 5% (4/75) versus 40% (30/75); risk difference -46%, 95% confidence interval -88% to -3%. Number needed-to-treat 2, 95% confidence interval 1 to 33. REVIEWER'S
CONCLUSIONS: Antibiotic regimens for treatment of leptospirosis is a form of care for which the evidence is insufficient to provide clear guidelines for practice. The randomised trials suggest that antibiotics could be a useful treatment for leptospirosis. Because of the questionable quality of two of the three trials, the indication for general use of antibiotics is uncertain. However, the evidence suggest that penicillin may cause more good than harm.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10796767     DOI: 10.1002/14651858.CD001306

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  12 in total

Review 1.  Leptospirosis in the family dog: a public health perspective.

Authors:  Ken Brown; John Prescott
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

2.  Differences in clinical manifestations of imported versus autochthonous leptospirosis in Austria and Germany.

Authors:  Bodo Hoffmeister; Gabriele Peyerl-Hoffmann; Sven Pischke; Ines Zollner-Schwetz; Robert Krause; Matthias C Müller; Angelika Graf; Stefan Kluge; Gerd D Burchard; Winfried V Kern; Norbert Suttorp; Jakob P Cramer
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

3.  Respiratory manifestations of leptospirosis: a retrospective study.

Authors:  P Tattevin; G Léveiller; R Flicoteaux; S Jauréguiberry; Y Le Tulzo; M Dupont; C Arvieux; C Michelet
Journal:  Lung       Date:  2005 Jul-Aug       Impact factor: 2.584

4.  Pediatric presentations of leptospirosis.

Authors:  Sarala Rajajee; Janani Shankar; Lata Dhattatri
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

5.  Cyclophosphamide in pulmonary alveolar hemorrhage due to leptospirosis.

Authors:  Samir V Trivedi; Ashwin H Vasava; Tinkal C Patel; Lovleen C Bhatia
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun

6.  Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center.

Authors:  Thomas Theo Brehm; Julian Schulze Zur Wiesch; Marc Lütgehetmann; Dennis Tappe; Philip Eisermann; Ansgar W Lohse; Marylyn M Addo; Stefan Schmiedel
Journal:  Infection       Date:  2018-07-17       Impact factor: 3.553

7.  Early diagnosis of leptospirosis by immunoglobulin M immunoblot testing.

Authors:  Galayanee Doungchawee; Uraiwan Kositanont; Anuchai Niwetpathomwat; Tasanee Inwisai; Plyyonk Sagarasaeranee; David A Haake
Journal:  Clin Vaccine Immunol       Date:  2008-01-09

8.  A rare case of leptospirosis with isolated lung involvement.

Authors:  Vijay Kumar Agrawal; Abhishek Bansal; Meenu Pujani
Journal:  Indian J Crit Care Med       Date:  2015-03

9.  Pulmonary manifestations of leptospirosis.

Authors:  Sameer Gulati; Anu Gulati
Journal:  Lung India       Date:  2012-10

10.  Antibiotics for the treatment of leptospirosis: systematic review and meta-analysis of controlled trials.

Authors:  Jaykaran Charan; Deepak Saxena; Summaiya Mulla; Preeti Yadav
Journal:  Int J Prev Med       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.